ALDEYRA THERAPEUTICS INC's ticker is and the CUSIP is 01438T956. A total of 3 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211 | -67.3% | 31,700 | -58.8% | 0.00% | -100.0% |
| Q2 2023 | $646 | +2.5% | 77,000 | +21.3% | 0.00% | 0.0% |
| Q1 2023 | $630 | -13.7% | 63,500 | -39.5% | 0.00% | 0.0% |
| Q4 2022 | $730 | -98.4% | 104,900 | +1105.7% | 0.00% | – |
| Q3 2022 | $46,000 | -48.9% | 8,700 | -61.7% | 0.00% | – |
| Q2 2022 | $90,000 | -95.1% | 22,700 | -94.5% | 0.00% | -100.0% |
| Q1 2022 | $1,838,000 | +50.9% | 413,700 | +35.8% | 0.00% | +100.0% |
| Q4 2021 | $1,218,000 | +2242.3% | 304,600 | +6521.7% | 0.00% | – |
| Q3 2021 | $52,000 | 0.0% | 4,600 | 0.0% | 0.00% | – |
| Q2 2021 | $52,000 | +10.6% | 4,600 | +11400.0% | 0.00% | – |
| Q1 2021 | $47,000 | -32.9% | 40 | -61.2% | 0.00% | – |
| Q4 2020 | $70,000 | +62.8% | 103 | +74.6% | 0.00% | – |
| Q3 2020 | $43,000 | +330.0% | 59 | +34.1% | 0.00% | – |
| Q1 2020 | $10,000 | -16.7% | 44 | +91.3% | 0.00% | – |
| Q3 2019 | $12,000 | -29.4% | 23 | -20.7% | 0.00% | – |
| Q2 2019 | $17,000 | -51.4% | 29 | -25.6% | 0.00% | – |
| Q1 2019 | $35,000 | -82.6% | 39 | -73.3% | 0.00% | -100.0% |
| Q3 2018 | $201,000 | +6600.0% | 146 | +3550.0% | 0.00% | – |
| Q2 2018 | $3,000 | – | 4 | +100.0% | 0.00% | – |
| Q1 2018 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,400 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 59 | $43,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |